Ab Corporate Bond Etf Performance
| EYEG Etf | USD 35.87 0.09 0.25% |
The entity owns a Beta (Systematic Risk) of 0.0733, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AB Corporate's returns are expected to increase less than the market. However, during the bear market, the loss of holding AB Corporate is expected to be smaller as well.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AB Corporate Bond are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, AB Corporate is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
1 | Every XRP Investor Should Keep an Eye on This Number in 2026 - The Motley Fool | 12/09/2025 |
2 | How Ab Corporate Bond Etf Affects Rotational Strategy Timing - Stock Traders Daily | 01/06/2026 |
AB Corporate Relative Risk vs. Return Landscape
If you would invest 3,548 in AB Corporate Bond on November 13, 2025 and sell it today you would earn a total of 39.00 from holding AB Corporate Bond or generate 1.1% return on investment over 90 days. AB Corporate Bond is currently generating 0.0184% in daily expected returns and assumes 0.2135% risk (volatility on return distribution) over the 90 days horizon. In different words, 1% of etfs are less volatile than EYEG, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AB Corporate Target Price Odds to finish over Current Price
The tendency of EYEG Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 35.87 | 90 days | 35.87 | about 1.15 |
Based on a normal probability distribution, the odds of AB Corporate to move above the current price in 90 days from now is about 1.15 (This AB Corporate Bond probability density function shows the probability of EYEG Etf to fall within a particular range of prices over 90 days) .
AB Corporate Price Density |
| Price |
Predictive Modules for AB Corporate
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AB Corporate Bond. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AB Corporate's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AB Corporate Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AB Corporate is not an exception. The market had few large corrections towards the AB Corporate's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AB Corporate Bond, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AB Corporate within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.34 |
AB Corporate Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AB Corporate for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AB Corporate Bond can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 12.06 K. Net Loss for the year was (9.47 M) with loss before overhead, payroll, taxes, and interest of (3.55 M). | |
| AB Corporate Bond currently holds about 3.66 M in cash with (8.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Volatility Zones as Tactical Triggers - Stock Traders Daily |
AB Corporate Fundamentals Growth
EYEG Etf prices reflect investors' perceptions of the future prospects and financial health of AB Corporate, and AB Corporate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EYEG Etf performance.
| Return On Equity | -103.8 | |||
| Return On Asset | -40.35 | |||
| Current Valuation | 18.1 M | |||
| Shares Outstanding | 7.1 M | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 1.55 X | |||
| Revenue | 12.06 K | |||
| EBITDA | (9.34 M) | |||
| Cash And Equivalents | 3.66 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 308.01 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (8.66 M) | |||
| Earnings Per Share | (1.77) X | |||
| Total Asset | 10.62 M | |||
| Retained Earnings | (108.16 M) | |||
| Current Asset | 6.26 M | |||
| Current Liabilities | 6.16 M | |||
About AB Corporate Performance
By analyzing AB Corporate's fundamental ratios, stakeholders can gain valuable insights into AB Corporate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AB Corporate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AB Corporate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.| The company reported the previous year's revenue of 12.06 K. Net Loss for the year was (9.47 M) with loss before overhead, payroll, taxes, and interest of (3.55 M). | |
| AB Corporate Bond currently holds about 3.66 M in cash with (8.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Volatility Zones as Tactical Triggers - Stock Traders Daily |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in AB Corporate Bond. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Investors evaluate AB Corporate Bond using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AB Corporate's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause AB Corporate's market price to deviate significantly from intrinsic value.
It's important to distinguish between AB Corporate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding AB Corporate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, AB Corporate's market price signifies the transaction level at which participants voluntarily complete trades.